Terms: = Ovarian cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Staging
5 results:
1. Guideline adherence in ovarian cancer for surgical staging in the Netherlands.
Baldewpersad Tewarie NMS; van Ham M; Wouters M; Kruitwagen R; van Driel W; ;
Int J Gynecol Cancer; 2022 Dec; 32(12):1592-1598. PubMed ID: 36270772
[TBL] [Abstract] [Full Text] [Related]
2. Mechanistically derived patient-level framework for precision medicine identifies a personalized immune prognostic signature in high-grade serous ovarian cancer.
Zhao H; Gu S; Bao S; Yan C; Zhang Z; Hou P; Zhou M; Sun J
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32436954
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of the time interval from primary surgery to intravenous chemotherapy in high grade serous ovarian cancer.
Feng Z; Wen H; Bi R; Yang W; Wu X
Gynecol Oncol; 2016 Jun; 141(3):466-470. PubMed ID: 27098361
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.
Zhang QW; Liu L; Gong CY; Shi HS; Zeng YH; Wang XZ; Zhao YW; Wei YQ
PLoS One; 2012; 7(12):e50946. PubMed ID: 23284651
[TBL] [Abstract] [Full Text] [Related]
5. Primary bilateral ovarian and uterine Burkitt's lymphoma following chemotherapy for breast cancer.
Hatami M; Whitney K; Goldberg GL
Arch Gynecol Obstet; 2010 Apr; 281(4):697-702. PubMed ID: 19756677
[TBL] [Abstract] [Full Text] [Related]
